Logo-npj
Submitted: 17 Oct 2021
Accepted: 01 Dec 2021
ePublished: 18 Dec 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Nephropharmacol. 2023;12(1): e10454.
doi: 10.34172/npj.2022.10454
  Abstract View: 9337
  PDF Download: 1103

Case Report

COVID-19-associated thrombotic thrombocytopenic purpura (TTP); a case report

Ali Hajigholami 1* ORCID logo, Hourieh Ansari 2 ORCID logo, Sakineh Ansari 1 ORCID logo, Shakiba Hassanzadeh 3 ORCID logo

1 Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Community and Preventive Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3 Nickan Research Institute, Isfahan, Iran
*Corresponding Author: Corresponding author: Ali Hajigholami, Email: , Email: alihajigholami@med.mui.ac.ir

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or coronavirus disease (COVID-19) pandemic is the largest infectious crisis in the present century. It has been reported that COVID-19 infection may trigger autoimmune diseases. Herein, we report a 68-year-old male that was diagnosed with thrombotic thrombocytopenic purpura (TTP) following COVID-19 infection. To our knowledge, this is the fourth case of COVID-19-associated TTP. More attention is required regarding the possibility of developing TTP in COVID-19 patients, especially with the presence of decreased consciousness and low levels of hemoglobin and platelet.

Implication for health policy/practice/research/medical education:

Coronavirus disease-19 (COVID-19) has been reported to trigger autoimmune diseases including thrombotic thrombocytopenic purpura (TTP). Therefore, more attention is recommended towards the possibility of developing TTP in COVID-19 patients.

Please cite this paper as: Hajigholami A, Ansari H, Ansari S, Hassanzadeh S. COVID-19-associated thrombotic thrombocytopenic purpura (TTP); a case report. J Nephropharmacol. 2023;12(1):e10454. DOI: 10.34172/npj.2022.10454.

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 9338

Your browser does not support the canvas element.


PDF Download: 1103

Your browser does not support the canvas element.